Related Experiment Video
Updated: Jul 4, 2026

Establishment of a Clinic-based Biorepository
Published on: May 29, 2017
Immunohistochemical determination of the P15 protein expression in cutaneous squamous cell carcinoma
Ahmed I Moad1, Tan Mei Lan, Gurjeet Kaur
1Advanced Medical and Dental Institute, University Sains Malaysia, Penang, Malaysia.
Abstract:
The tumor suppressor gene p15(INK4b) is a cyclin-dependent kinase inhibitor, in which its inactivation has been determined in primary tumors and in several tumor-derived cell lines. The precise role of p15(INK4b) protein expression in cutaneous squamous cell carcinoma (SCC) is currently not known. In a previous study, we have shown the frequent occurrence of allelic imbalance/loss of heterozygosity in cutaneous SCC using two microsatellite markers flanking the p15(INK4b) gene. This study is a continuation of our previous study and aims to determine the possible role of p15(INK4b) protein expression in the genesis of cutaneous SCC. P15(INK4b) protein expression was determined using immunohistochemical approach in 107 cases of cutaneous SCC tissue arrays and 19 cases of normal human skin tissues. The expression of p15(INK4b) was significantly reduced in the cutaneous SCC cases as compared with normal human skin (p = 0.017 and p < 0.05). However, there were no significant relationship between clinicopathologic variables of the patients (age, sex and tumor grade) and p15(INK4b) protein expression. The absence of p15(INK4b) expression in the majority of tissue microarray cores of cutaneous SCC indicated that p15(INK4b) could possibly be involved in the pathogenesis of cutaneous SCC.
Insights
The tumor suppressor p15(INK4b) protein is significantly reduced in cutaneous squamous cell carcinoma (SCC). Its absence suggests a role in the development of this common skin cancer.
Area of Science:
- Oncology
- Dermatology
- Molecular Biology
Background:
- The tumor suppressor gene p15(INK4b) encodes a cyclin-dependent kinase inhibitor.
- Inactivation of p15(INK4b) is observed in various cancers, but its role in cutaneous squamous cell carcinoma (SCC) is unclear.
- Previous research indicated frequent allelic imbalance/loss of heterozygosity at the p15(INK4b) locus in cutaneous SCC.
Purpose of the Study:
- To investigate the expression of p15(INK4b) protein in cutaneous SCC.
- To determine the potential role of p15(INK4b) in the pathogenesis of cutaneous SCC.
Main Methods:
- Immunohistochemical analysis of p15(INK4b) protein expression.
- Evaluation in 107 cases of cutaneous SCC and 19 normal human skin tissues using tissue arrays.
Main Results:
- P15(INK4b) protein expression was significantly reduced in cutaneous SCC compared to normal skin (p = 0.017 and p < 0.05).
- No significant correlation was found between p15(INK4b) expression and clinicopathologic variables (age, sex, tumor grade).
- Absence of p15(INK4b) expression was noted in a majority of SCC tissue cores.
Conclusions:
- Reduced p15(INK4b) protein expression is a feature of cutaneous SCC.
- The findings suggest that p15(INK4b) may play a role in the development of cutaneous squamous cell carcinoma.
